Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Enzalutamide dose reduction for fatigue and cognition in prostate cancer
NCT03124615Phase 2Unknown
- Sponsor
- Macquarie University
- Start
- May 2017
- Primary completion
- Dec 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of enzalutamide in prostate cancer (PCa), sponsored by Macquarie University. Status: unknown.
02
Drugs
enzalutamide
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT03124615.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03124615.